Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
about
HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responsesImmunogenicity of HLA Class I and II Double Restricted Influenza A-Derived PeptidesMHC class II epitope predictive algorithms.High-throughput engineering and analysis of peptide binding to class II MHCNetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure.A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applications.A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 1-theoretical model.Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display.MHC class II tetramers made from isolated recombinant α and β chains refolded with affinity-tagged peptides.Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.Current tools for predicting cancer-specific T cell immunity.A high throughput MHC II binding assay for quantitative analysis of peptide epitopes.Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.Post hoc assessment of the immunogenicity of bioengineered factor VIIa demonstrates the use of preclinical tools.An automated benchmarking platform for MHC class II binding prediction methods.Immunogenicity assessment during the development of protein therapeutics.
P2860
Q28473871-C517BE29-C9C2-4CF9-A33F-F10F7059586AQ28552077-9910C3AF-E9EF-4EFE-9D36-E553F46344AAQ30388353-83C38511-3DB6-4433-BA04-AA6EA1537C33Q33630225-3C09C8A5-6CA8-4AD5-8952-D4D4DBE403ACQ34366463-99601C7D-1362-41DF-BA13-B03E73D63E85Q34413009-1F9872D6-E853-4B71-8DDA-CDC20D699A2AQ34413016-5FFDF391-E54B-4403-811C-E3D5E33F5BD8Q34567347-317A8899-8162-4F1F-859F-2717D5FA6580Q34984511-C964EF5C-1E43-45EF-BE16-C28EEE5DFDE0Q35156297-364FA370-FBAA-448B-B630-700B2FE98003Q36260214-1DEFD037-C245-4EFB-A8C5-829D18AAC69CQ36386903-E3FDFEC5-5DA4-4B00-90D8-1AC8E022E2F2Q38953021-D6C652B6-D3CD-4D0D-914D-3D741F4F6DC0Q39766269-2D9CB05B-6C1B-4695-982E-009218A18047Q39786340-2BDE3C51-2EC3-413E-B82B-7A0A6CEBA410Q39849181-4FE7ADD1-AD8F-443F-9BBF-38B24866FF94Q45863538-5B0F96F9-CEE8-425F-ADCA-47E21EA65113Q47243904-43482CA9-9BF4-40C5-8739-F2ADA227EA25Q47855368-CF5DD4F4-E4DB-4565-9486-4AF8491AFB5E
P2860
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@en
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@nl
type
label
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@en
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@nl
prefLabel
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@en
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@nl
P2093
P2860
P356
P1433
P1476
Functional recombinant MHC class II molecules and high-throughput peptide-binding assays.
@en
P2093
Kasper Lamberth
Lise-Lotte B Nielsen
Mikkel Harndahl
Sune Justesen
P2860
P2888
P356
10.1186/1745-7580-5-2
P50
P577
2009-05-05T00:00:00Z
P5875
P6179
1016661547